February 7, 2025
ProMIS Neurosciences to Present New Preclinical Data for PMN310 at AD/PD 2023

Mar 13, 2023 ProMIS Neurosciences   [PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Massachusetts – March 13, 2023 – ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *